Mesoblast (MESO) Shares Outstanding (Weighted Average) (2015 - 2025)

Mesoblast has disclosed Shares Outstanding (Weighted Average) across 11 years of filings, most recently posting $1.5 billion for Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $1.5 billion, up 15.09% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.5 billion (up 15.09% YoY), and the FY2025 annual result was $1.5 billion, up 15.11% from the prior year.
• Shares Outstanding (Weighted Average) came in at $1.5 billion for Q4 2025 at Mesoblast, up from $1.5 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.5 billion in Q4 2025 to a low of $682.9 million in Q2 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $1.2 billion (2023), against an average of $1.2 billion.
• Across the five-year window, Shares Outstanding (Weighted Average) slumped 41.29% in 2022 and surged 61.1% in 2024, its largest moves.
• Mesoblast's Shares Outstanding (Weighted Average) stood at $1.2 billion in 2021, then increased by 3.79% to $1.2 billion in 2022, then advanced by 6.5% to $1.3 billion in 2023, then climbed by 2.64% to $1.3 billion in 2024, then climbed by 15.09% to $1.5 billion in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $1.5 billion (Q4 2025), $1.5 billion (Q2 2025), and $1.3 billion (Q4 2024), per Business Quant data.